Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Asian Journal of Psychiatry|April 18, 2021
Risk factors for clozapine-induced central nervous system abnormalities in Japanese patients with treatment-resistant schizophreniaKohei Kitagawa, Shusuke Uekusa, Kazuhiro Matsuo, et al.Psychopharmacology|August 6, 2024
Impact of clozapine once-daily versus multiple-daily dosing regimen on relapse in patients with treatment-resistant schizophrenia: A 1-year retrospective cohort studyMasaru Tsukahara, Ryuhei So, Kohei Kitagawa, et al.Chemical Communications (Cambridge, England)|May 11, 2023
Mechanism of rate controllability of water-soluble bifunctional cyclooctadiynes through cation-anion interactionsMoeka Yoshinaga, Fumiya Sato, Kohei Kitagawa, et al.Human Psychopharmacology|January 18, 2012
Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009Takashi Yoshio, Toshiya Inada, Junji Uno, et al.International Clinical Psychopharmacology|January 25, 2021
Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychoticsNozomi Nakajima, Nao Mizoe, Fuminari Misawa, et al.Acta Psychiatrica Scandinavica|December 4, 2020
The relationship between plasma clozapine concentration and clinical outcome: a cross-sectional studyYuji Yada, Kohei Kitagawa, Shinji Sakamoto, et al.Therapeutic Advances in Psychopharmacology|May 28, 2021
Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic studyNobuyuki Nomura, Kohei Kitagawa, Ryuhei So, et al.Bioconjugate Chemistry|February 10, 2023
Ion-Pair-Enhanced Double-Click Driven Cell Adhesion and Altered Expression of Related GenesKohei Kitagawa, Nao Okuma, Moeka Yoshinaga, et al.Journal of Clinical Psychopharmacology|December 8, 2021
Clozapine Once-Daily Versus Divided Dosing Regimen: A Cross-sectional Study in JapanKohei Kitagawa, Ryuhei So, Nobuyuki Nomura, et al.Molecular Brain|March 17, 2021
Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZWT/Q1038R mouse model of autism spectrum disorderKohei Kitagawa, Kensuke Matsumura, Masayuki Baba, et al.Pageof 3